デフォルト表紙
市場調査レポート
商品コード
1347528

医薬品ドラッグデリバリー市場:世界の産業動向、シェア、規模、成長、機会、2023-2028年予測

Pharmaceutical Drug Delivery Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

出版日: | 発行: IMARC | ページ情報: 英文 138 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=160.11円
医薬品ドラッグデリバリー市場:世界の産業動向、シェア、規模、成長、機会、2023-2028年予測
出版日: 2023年09月04日
発行: IMARC
ページ情報: 英文 138 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

市場概要:

世界の医薬品ドラッグデリバリー市場規模は、2022年に1兆3,250億米ドルに達しました。今後、IMARC Groupは、2023年から2028年にかけて5.5%の成長率(CAGR)を示し、2028年までに1兆8,480億米ドルに達すると予測しています。

医薬品ドラッグデリバリーは、治療物質を体内に投与する方法です。薬物放出の速度、時間、場所を制御することにより、効率性、安全性、患者の体感を向上させる。現在、様々な治療薬を放出するために、様々なタイプのドラッグデリバリーシステムが利用可能です。例えば、ゲル、リポソーム、マイクロスフェア、プロドラッグ、シクロデキストリンなどは、ペプチドやタンパク質の治療薬に使用される効果的なシステムのひとつです。

医薬品ドラッグデリバリー市場の動向:

呼吸器感染症、リーシュマニア症、中枢神経系(CNS)感染症、全身性真菌感染症などの疾患の有病率の増加は、市場の成長を後押しする重要な要因の1つです。さらに、高齢者やがん患者の死亡率の大幅な増加が、ドラッグデリバリーシステムに対する需要を喚起しています。これらのシステムは抗がん剤の有効性を高め、毒性を軽減します。この市場はまた、個別化医療や低侵襲(MI)医療に対する消費者の志向にも影響されています。これとは別に、生分解性ポリマーから成るナノ粒子は、脳へのドラッグデリバリーを強化するために人気を集めています。ナノ粒子はまた、多くの国の行政機関がドラッグデリバリーシステムに課している厳しい要件を満たすのにも役立っています。これらの要件には一般に、エアロゾル化中に発生する力に対する安定性、生体適合性、肺の特定の部位や細胞集団を標的とすること、所定の方法で薬物を放出すること、許容期間内に分解されることなどが含まれます。これに伴い、研究者は新しいドラッグデリバリーシステムの開発に注力しており、これが市場開拓に寄与しています。さらに、世界中でコロナウイルス感染症(COVID-19)の患者が急増していることから、医薬品に対する需要が増加しており、これが市場の成長を促進すると予想されています。

本レポートで扱う主な質問

  • 世界の医薬品ドラッグデリバリー市場はこれまでどのように推移してきたか?
  • COVID-19が世界の医薬品ドラッグデリバリー市場に与えた影響は?
  • 主要な地域市場は?
  • 投与経路に基づく市場内訳は?
  • 用途別の市場内訳は?
  • エンドユーザー別の市場内訳は?
  • 業界のバリューチェーンにおける様々な段階とは?
  • 業界の主要な促進要因と課題は何か?
  • 世界の医薬品ドラッグデリバリー市場の構造と主要プレーヤーは?
  • 業界における競合の程度は?

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 世界の医薬品ドラッグデリバリー市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳:投与経路別

  • 経口ドラッグデリバリー
    • 市場動向
    • 市場予測
  • 注射ドラッグデリバリー
    • 市場動向
    • 市場予測
  • 局所ドラッグデリバリー
    • 市場動向
    • 市場予測
  • 経強膜ドラッグデリバリー
    • 市場動向
    • 市場予測
  • 経肺ドラッグデリバリー
    • 市場動向
    • 市場予測
  • 埋め込み型ドラッグデリバリー
    • 市場動向
    • 市場予測
  • 経粘膜ドラッグデリバリー
    • 市場動向
    • 市場予測
  • 経鼻ドラッグデリバリー
    • 市場動向
    • 市場予測

第7章 市場内訳:用途別

  • 感染症
    • 市場動向
    • 市場予測
  • がん
    • 市場動向
    • 市場予測
  • 心血管疾患
    • 市場動向
    • 市場予測
  • 糖尿病
    • 市場動向
    • 市場予測
  • 呼吸器疾患
    • 市場動向
    • 市場予測
  • 中枢神経系疾患
    • 市場動向
    • 市場予測
  • 自己免疫疾患
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第8章 市場内訳:エンドユーザー別

  • 病院
    • 市場動向
    • 市場予測
  • 外来手術センター
    • 市場動向
    • 市場予測
  • 在宅ケア
    • 市場動向
    • 市場予測
  • 診断センター
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第9章 市場内訳:地域別

  • 北米
    • 米国
      • 市場動向
      • 市場予測
    • カナダ
      • 市場動向
      • 市場予測
  • アジア太平洋
    • 中国
      • 市場動向
      • 市場予測
    • 日本
      • 市場動向
      • 市場予測
    • インド
      • 市場動向
      • 市場予測
    • 韓国
      • 市場動向
      • 市場予測
    • オーストラリア
      • 市場動向
      • 市場予測
    • インドネシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 欧州
    • ドイツ
      • 市場動向
      • 市場予測
    • フランス
      • 市場動向
      • 市場予測
    • 英国
      • 市場動向
      • 市場予測
    • イタリア
      • 市場動向
      • 市場予測
    • スペイン
      • 市場動向
      • 市場予測
    • ロシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • ラテンアメリカ
    • ブラジル
      • 市場動向
      • 市場予測
    • メキシコ
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 中東・アフリカ地域
    • 市場動向
    • 市場内訳:国別
    • 市場予測

第10章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第11章 バリューチェーン分析

第12章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第13章 価格分析

第14章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • AbbVie Inc.
    • Amgen Inc.
    • AstraZeneca plc
    • Becton Dickinson and Company
    • Eli Lilly and Company
    • GSK plc
    • Johnson & Johnson
    • Merck KGaA
    • Novartis AG
    • Pfizer Inc.
    • Sanofi S.A.
図表

List of Figures

  • Figure 1: Global: Pharmaceutical Drug Delivery Market: Major Drivers and Challenges
  • Figure 2: Global: Pharmaceutical Drug Delivery Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Pharmaceutical Drug Delivery Market: Breakup by Route of Administration (in %), 2022
  • Figure 5: Global: Pharmaceutical Drug Delivery Market: Breakup by Application (in %), 2022
  • Figure 6: Global: Pharmaceutical Drug Delivery Market: Breakup by End User (in %), 2022
  • Figure 7: Global: Pharmaceutical Drug Delivery Market: Breakup by Region (in %), 2022
  • Figure 8: Global: Pharmaceutical Drug Delivery (Oral Drug Delivery) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 9: Global: Pharmaceutical Drug Delivery (Oral Drug Delivery) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 10: Global: Pharmaceutical Drug Delivery (Injectable Drug Delivery) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Pharmaceutical Drug Delivery (Injectable Drug Delivery) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Pharmaceutical Drug Delivery (Topical Drug Delivery) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Pharmaceutical Drug Delivery (Topical Drug Delivery) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Pharmaceutical Drug Delivery (Ocular Drug Delivery) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Pharmaceutical Drug Delivery (Ocular Drug Delivery) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Pharmaceutical Drug Delivery (Pulmonary Drug Delivery) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Pharmaceutical Drug Delivery (Pulmonary Drug Delivery) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Pharmaceutical Drug Delivery (Implantable Drug Delivery) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Pharmaceutical Drug Delivery (Implantable Drug Delivery) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Pharmaceutical Drug Delivery (Transmucosal Drug Delivery) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Pharmaceutical Drug Delivery (Transmucosal Drug Delivery) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Pharmaceutical Drug Delivery (Nasal Drug Delivery) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Pharmaceutical Drug Delivery (Nasal Drug Delivery) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Global: Pharmaceutical Drug Delivery (Infectious Diseases) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Global: Pharmaceutical Drug Delivery (Infectious Diseases) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: Global: Pharmaceutical Drug Delivery (Cancer) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: Global: Pharmaceutical Drug Delivery (Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: Global: Pharmaceutical Drug Delivery (Cardiovascular Diseases) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: Global: Pharmaceutical Drug Delivery (Cardiovascular Diseases) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: Global: Pharmaceutical Drug Delivery (Diabetes) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: Global: Pharmaceutical Drug Delivery (Diabetes) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: Global: Pharmaceutical Drug Delivery (Respiratory Diseases) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: Global: Pharmaceutical Drug Delivery (Respiratory Diseases) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: Global: Pharmaceutical Drug Delivery (Central Nervous System Disorders) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: Global: Pharmaceutical Drug Delivery (Central Nervous System Disorders) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: Global: Pharmaceutical Drug Delivery (Autoimmune Diseases) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: Global: Pharmaceutical Drug Delivery (Autoimmune Diseases) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: Global: Pharmaceutical Drug Delivery (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: Global: Pharmaceutical Drug Delivery (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: Global: Pharmaceutical Drug Delivery (Hospitals) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: Global: Pharmaceutical Drug Delivery (Hospitals) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: Global: Pharmaceutical Drug Delivery (Ambulatory Surgery Centers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: Global: Pharmaceutical Drug Delivery (Ambulatory Surgery Centers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: Global: Pharmaceutical Drug Delivery (Home Care Settings) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: Global: Pharmaceutical Drug Delivery (Home Care Settings) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: Global: Pharmaceutical Drug Delivery (Diagnostic Centers) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: Global: Pharmaceutical Drug Delivery (Diagnostic Centers) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: Global: Pharmaceutical Drug Delivery (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: Global: Pharmaceutical Drug Delivery (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: North America: Pharmaceutical Drug Delivery Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: North America: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: United States: Pharmaceutical Drug Delivery Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: United States: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: Canada: Pharmaceutical Drug Delivery Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: Canada: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: Asia-Pacific: Pharmaceutical Drug Delivery Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: Asia-Pacific: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: China: Pharmaceutical Drug Delivery Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: China: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: Japan: Pharmaceutical Drug Delivery Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: Japan: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: India: Pharmaceutical Drug Delivery Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: India: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: South Korea: Pharmaceutical Drug Delivery Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: South Korea: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: Australia: Pharmaceutical Drug Delivery Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: Australia: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Indonesia: Pharmaceutical Drug Delivery Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: Indonesia: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Others: Pharmaceutical Drug Delivery Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: Others: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 72: Europe: Pharmaceutical Drug Delivery Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 73: Europe: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 74: Germany: Pharmaceutical Drug Delivery Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 75: Germany: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 76: France: Pharmaceutical Drug Delivery Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 77: France: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 78: United Kingdom: Pharmaceutical Drug Delivery Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 79: United Kingdom: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 80: Italy: Pharmaceutical Drug Delivery Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 81: Italy: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 82: Spain: Pharmaceutical Drug Delivery Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 83: Spain: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 84: Russia: Pharmaceutical Drug Delivery Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 85: Russia: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 86: Others: Pharmaceutical Drug Delivery Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 87: Others: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 88: Latin America: Pharmaceutical Drug Delivery Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 89: Latin America: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 90: Brazil: Pharmaceutical Drug Delivery Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 91: Brazil: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 92: Mexico: Pharmaceutical Drug Delivery Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 93: Mexico: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 94: Others: Pharmaceutical Drug Delivery Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 95: Others: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 96: Middle East and Africa: Pharmaceutical Drug Delivery Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 97: Middle East and Africa: Pharmaceutical Drug Delivery Market: Breakup by Country (in %), 2022
  • Figure 98: Middle East and Africa: Pharmaceutical Drug Delivery Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 99: Global: Pharmaceutical Drug Delivery Industry: SWOT Analysis
  • Figure 100: Global: Pharmaceutical Drug Delivery Industry: Value Chain Analysis
  • Figure 101: Global: Pharmaceutical Drug Delivery Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Pharmaceutical Drug Delivery Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Pharmaceutical Drug Delivery Market Forecast: Breakup by Route of Administration (in Million US$), 2023-2028
  • Table 3: Global: Pharmaceutical Drug Delivery Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 4: Global: Pharmaceutical Drug Delivery Market Forecast: Breakup by End User (in Million US$), 2023-2028
  • Table 5: Global: Pharmaceutical Drug Delivery Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 6: Global: Pharmaceutical Drug Delivery Market: Competitive Structure
  • Table 7: Global: Pharmaceutical Drug Delivery Market: Key Players
目次
Product Code: SR112023A5796

Market Overview:

The global pharmaceutical drug delivery market size reached US$ 1,325 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 1,848 Billion by 2028, exhibiting a growth rate (CAGR) of 5.5% during 2023-2028.

Pharmaceutical drug delivery is a method of administering therapeutic substances into the body. It improves efficiency, safety, and patient experience by controlling the rate, time, and place of drug release. At present, different types of drug delivery systems are available for the release of various therapeutic agents. For instance, gels, liposomes, microspheres, prodrugs, and cyclodextrins are among the effective systems used for peptide and protein therapeutics.

Pharmaceutical Drug Delivery Market Trends:

The growing prevalence of diseases, such as respiratory, leishmaniasis, central nervous system (CNS), and systemic fungal infections, represents one of the key factors bolstering the market growth. Moreover, a significant increase in the number of death rates among the older population and individuals who have cancer is catalyzing the demand for pharmaceutical drug delivery systems. These systems provide enhanced efficacy and reduced toxicity for anticancer agents. The market is also influenced by consumer inclination towards personalized and minimally invasive (MI) medical therapy. Apart from this, nanoparticles composed of biodegradable polymers are gaining popularity for enhancing drug delivery to the brain. They also assist in fulfilling the stringent requirements placed on drug delivery systems by governing agencies of numerous countries. These requirements generally include stability against forces generated during aerosolization, biocompatibility, targeting specific sites or cell populations in the lung, drug release in a predetermined manner, and degradation within an acceptable period. In line with this, researchers are focusing on developing new drug delivery systems, which is contributing to market growth. Furthermore, with the surging cases of coronavirus disease (COVID-19) across the globe, there is a rise in the demand for pharmaceutical drugs, which, in turn, is anticipated to fuel the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global pharmaceutical drug delivery market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on route of administration, application and end user.

Breakup by Route of Administration:

Oral Drug Delivery

Injectable Drug Delivery

Topical Drug Delivery

Ocular Drug Delivery

Pulmonary Drug Delivery

Implantable Drug Delivery

Transmucosal Drug Delivery

Nasal Drug Delivery

Breakup by Application:

Infectious Diseases

Cancer

Cardiovascular Diseases

Diabetes

Respiratory Diseases

Central Nervous System Disorders

Autoimmune Diseases

Others

Breakup by End User:

Hospitals

Ambulatory Surgery Centers

Home Care Settings

Diagnostic Centers

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being AbbVie Inc., Amgen Inc., AstraZeneca plc, Becton Dickinson and Company, Eli Lilly and Company, GSK plc, Johnson & Johnson, Merck KGaA, Novartis AG, Pfizer Inc. and Sanofi S.A.

Key Questions Answered in This Report:

  • How has the global pharmaceutical drug delivery market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global pharmaceutical drug delivery market?
  • What are the key regional markets?
  • What is the breakup of the market based on the route of administration?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global pharmaceutical drug delivery market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Pharmaceutical Drug Delivery Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Route of Administration

  • 6.1 Oral Drug Delivery
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Injectable Drug Delivery
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Topical Drug Delivery
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Ocular Drug Delivery
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Pulmonary Drug Delivery
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Implantable Drug Delivery
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast
  • 6.7 Transmucosal Drug Delivery
    • 6.7.1 Market Trends
    • 6.7.2 Market Forecast
  • 6.8 Nasal Drug Delivery
    • 6.8.1 Market Trends
    • 6.8.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Infectious Diseases
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Cancer
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Cardiovascular Diseases
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Diabetes
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Respiratory Diseases
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Central Nervous System Disorders
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast
  • 7.7 Autoimmune Diseases
    • 7.7.1 Market Trends
    • 7.7.2 Market Forecast
  • 7.8 Others
    • 7.8.1 Market Trends
    • 7.8.2 Market Forecast

8 Market Breakup by End User

  • 8.1 Hospitals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Ambulatory Surgery Centers
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Home Care Settings
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Diagnostic Centers
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 AbbVie Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
      • 14.3.1.4 SWOT Analysis
    • 14.3.2 Amgen Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 AstraZeneca plc
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Becton Dickinson and Company
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 Financials
      • 14.3.4.4 SWOT Analysis
    • 14.3.5 Eli Lilly and Company
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 GSK plc
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Johnson & Johnson
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
      • 14.3.7.4 SWOT Analysis
    • 14.3.8 Merck KGaA
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 Financials
      • 14.3.8.4 SWOT Analysis
    • 14.3.9 Novartis AG
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 Pfizer Inc.
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Sanofi S.A.
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials